Clinical Trials Logo

Neoplasms by Histologic Type clinical trials

View clinical trials related to Neoplasms by Histologic Type.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT05592743 Available - Neoplasms Clinical Trials

Vorasidenib Expanded Access Program

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access program to provide vorasidenib for treatment of patients 12 years or older with IDH1- or IDH2-mutated glioma.